Unleashing economic potential of AI-driven technology to prevent adverse events and sub-optimal treatment.

Journal: Expert review of pharmacoeconomics & outcomes research
Published Date:

Abstract

No abstract available for this article.

Authors

  • L Maas
    Radiomics.bio, Liege, Belgium.
  • C Contreras-Meca
    Radiomics.bio, Liege, Belgium.
  • W Vos
    Radiomics.bio, Liege, Belgium.
  • M Hiligsmann
    Department of Health Services Research, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Keywords

No keywords available for this article.